logo
logo
Sign in

Bone Tumor Ablation Devices Market Will Grow At Highest Pace Owing To Technological Innovation

avatar
Gauri Cmi


The bone tumor ablation devices market has experienced significant growth in recent years. Bone tumor ablation devices utilize minimally invasive procedures such as radiofrequency ablation, microwave ablation and cryoablation to treat bone tumors. These procedures provide advantages over traditional surgical methods such as reduced recovery time, fewer complications and scarring. The minimally invasive nature of ablation techniques help preserve bone structure and function while destroying cancerous cells.

The global bone tumor ablation devices market is estimated to be valued at US$ 1.93 Mn  in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period of 2024 to 2030.

Key Takeaways

Key players operating in the Global Bone Tumor Ablation Devices Market Size are Xikar, Colibri, Vertigo, Cuban Crafters, Milwaukee, Tailor Made Cigar Company, Rocky Patel, Elie Bleu, CRAFTD, Cigar Cutter Direct, Quality Importers, Tonino Lamborghini, Oliva Cigar Company, Gurkha, Ashton, Davidoff, Alec Bradley, Rocky's Cigar, Villiger, Lotus. Leading players like Medtronic and Boston Scientific are investing in R&D to develop advanced bone tumor ablation systems.

The increasing incidence of bone cancer is driving the demand for effective treatment options. According to cancer research UK, around 2,300 new bone cancer cases are diagnosed annually in the UK alone. Bone tumor ablation devices offer an appealing alternative to surgery due to benefits like short recovery time and ambulatory care.

Technological advancements in tumor ablation such as magnetic resonance-guided focused ultrasound and irreversible electroporation are expanding the scope of treatments. Development of cryoablation probes and microwave ablation devices with real-time monitoring capability is also enhancing procedure accuracy.

Market Trends

Adoption of Artificial Intelligence (AI): Major players are investing in AI and machine learning integration to guide ablation procedures and produce more precise treatment outcomes. AI can help optimize ablation zone shape, size and temperature distribution.

Multi-cancer Ablation Platforms: Manufacturers are developing versatile platforms capable of treating different tumor types through a single system. This reduces costs and expands the applicability of ablation devices.

Market Opportunities

Rise in Diagnosis Rates in Developing Nations: Increasing healthcare access and improved diagnostic capabilities in developing countries will spur the demand for bone cancer treatment devices like ablation systems over the coming decade.

Combination with Checkpoint Inhibitors: Ongoing clinical trials are evaluating the efficacy of combining tumor ablation with immunotherapy drugs. A promising combination therapy can offer a less invasive alternative to surgery.

Impact of COVID-19 on Bone Tumor Ablation Devices Market

The COVID-19 pandemic has significantly impacted the bone tumor ablation devices market. During the initial lockdown phases imposed worldwide to curb virus transmission, non-critical surgical procedures were postponed or cancelled to avoid virus exposure and reserve hospital resources for COVID-19 patients. This led to a decline in bone tumor ablation procedures performed during 2020-2021. In addition, supply chain disruptions and trade restrictions resulted in delayed shipments and shortage of important components used in bone tumor ablation devices, negatively hitting market revenues.

However, as lockdowns eased from late 2021, the postponed surgeries resumed which helped drive market demand to some extent. Going forward, as the pandemic situation improves globally with increasing vaccination rates, the number of bone tumor ablation procedures performed is expected to normalize gradually. Device manufacturers are also expanding their production capacities and streamlining supply chains to ensure sufficient product availability. Various government initiatives are further augmenting healthcare spending to address the backlog of non-COVID cases. With the COVID-19 impact receding, the bone tumor ablation devices market is anticipated to regain its pre-pandemic growth trajectory over the forecast period.

In terms of value, North America accounted for the largest share of the bone tumor ablation devices market in 2024 owing to robust healthcare infrastructure, high adoption of advanced cancer treatment options and presence of major market players in the region. Going forward, Asia Pacific is poised to witness the fastest market growth during the forecast period. This can be attributed to growing healthcare expenditure, rising cancer incidence rates and increasing medical tourism across developing countries of China, India and Southeast Asian nations.

Europe held the second largest regional market share in 2024 supported by favorable reimbursement scenarios, technological advancements and presence of key industry stakeholders in the region. Additionally, Latin America and Middle East & Africa are also projected to showcase significant growth opportunities for bone tumor ablation devices market participants during the forecast period.

 

Get More Insights On This Topic: Bone Tumor Ablation Devices Market


collect
0
avatar
Gauri Cmi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more